CNBC’s Investing Club with Jim Cramer released its daily update, highlighting market moves and key earnings announcements. On Thursday, stocks rose as the technology and industrials sectors drove gains in the S&P 500, while real estate and healthcare weighed on the index.
Amazon cut jobs at its Amazon Web Services cloud computing division, but analysts believe this move is aimed at increasing efficiency rather than signaling slowing demand. This trend of cost-cutting measures among large tech companies, including Dell and Microsoft, could lead to improved earnings leverage in the future.
In the pharmaceutical sector, Bristol Myers Squibb and Pfizer announced a plan to sell Eliquis directly to patients through their Eliquis 360 support program at a 40% discount. While analysts expect significant revenue from this move, they do not anticipate it will negatively impact profits. The companies’ ability to circumvent middlemen with these programs could help them gain favor with the Trump Administration and alleviate concerns about drug pricing reform.
Jim Cramer’s Investing Club is long on Amazon, Microsoft, Bristol Myers Squibb, and other stocks, but he waits for further data before making decisions. Key earnings announcements include reports from Netflix, Interactive Brokers, American Express, Charles Schwab, 3M, and the University of Michigan consumer sentiment survey.
Note: Jim Cramer’s Investing Club is a paid service that provides trade alerts and investment advice. Please review the terms and conditions and disclaimer before subscribing.
Source: https://www.cnbc.com/2025/07/17/bristol-myers-goes-dtc-on-a-blockbuster-drug-heres-our-take.html